Zhitong Finance App News, Siludi Pharmaceutical Co., Ltd. (01244.HK) issued an announcement. The board of directors of the Company is pleased to announce the latest developments in the dispute case involving SELLAS Life Sciences Group, Inc. (SELLAS). The case was fully reviewed by the Hong Kong International Arbitration Centre, covering the entire evidentiary presentation and debate process, and a final ruling was issued after trial by a sole arbitrator.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.